The risks and benefits of a low protein-essential amino acid-keto acid diet. Twelve patients with progressive renal failure were placed on a very low protein diet supplemented by an essential amino acid-keto acid mixture for six to twelve months. Total daily intake was 0.04 g nitrogen/kg and 50 kcal/kg. Eight subjects had a significant change in the slope of reciprocal plasma creatinine, becoming less steep and in two cases positive. GFR did not improve, but in four patients the decline over twelve months was less than 0.5 muter/mm. There were significant falls in blood and urinary urea, serum phosphate P'FH and calcium X phosphate product. Body wt decreased during the first three months. Arm muscle circumference fell by 0.9 cm (P < 0.005). Serum albumin and transferrin levels did not change significantly. Muscle mass and plasma creatinine fell simultaneously in several patients. Creatinine excretion per kg muscle mass, assessed anthropometrically, declined by 21% in the first three months. This diet may slow the decline in renal function in a proportion of patients. However, muscle mass can be lost. Serum protein levels do not accurately reflect nutritional changes. A fall in plasma creatinine may not be due to improved GFR but instead to altered creatinine metabolism.
Low protein diets have been used for many years for symptomatic relief of uremic symptoms. In an attempt to improve the uremic state various combinations of essential amino acids and their keto acid analogues (EAA/KAA) have been given as supplements to diets low in nitrogen [1] [2] [3] [4] [5] .
Recently it has been claimed that low protein diets may slow the progression of renal failure [6, 7] . The evidence for a protective effect of a low protein intake is striking in experimental renal failure produced in rats by subtotal nephrectomy [8] or glomerulonephritis [9] . A number of reports have appeared which suggest there may be a similar effect in man [10] [11] [12] [13] [14] but to date there has been only one attempt at a prospective randomly allocated trial in human renal disease [15] .
Barsotti et al [16] reported that a very low protein diet supplemented by an essential amino acid/keto acid mixture appeared to slow or in some cases completely halt the progression of advanced renal failure. If decline in renal function can indeed be arrested by such regimes, they would prove to be of enormous importance in both human and economic terms. The results of Barsotti et al were sufficiently striking to demand a regime was used to treat large numbers of patients, there should be an assessment of the possible risks as well as of benefits. We, therefore, investigated the effects of a very similar diet on a comparable group of patients. In addition to reporting changes in renal function, we also present detailed information on the metabolic and nutritional consequences of this regime together with more limited information on subjective responses.
Methods

Patients
Adult patients with chronic renal failure were selected on the following criteria: 1. The presence of progressive chronic renal failure as judged by a declining slope of reciprocal plasma creatinine. The slope was plotted from a minimum of six separate measurements over at least 16 months. 2. The absence of any reversible factor such as salt depletion or untreated hypertension. 3. The probability of the need for renal replacement therapy within one year as judged by projection of the reciprocal plasma creatinine. This event was arbitrarily assumed to be at a point when plasma creatinine reached between 1000 and 1500 mole/liter. Nineteen patients fulfilling these criteria were started on the regime. Twelve patients followed it for over six months each, with a mean time on the diet of 12.25 months (range 6 to 24) giving a total of 147 patient months of treatment. Potential subjects were informed as to the experimental nature of the regime and of the likelihood of their needing renal replacement therapy in the near future. Patients whose renal function subsequently became inadequate were started on dialysis when appropriate and all are still alive.
Approval for this study was given by the Cardiff Division of Medicine Ethical Committee.
Diet and drugs
A similar regime to the one reported by Barsotti et al [16] was used, the main difference being the increased calorie content of our diet. A very low protein intake (0.032 glkglday of nitrogen) was supplied almost entirely as vegetable protein. This was supplemented by an EAA/KAA mixture [5, 16] . Details of the complete daily intake including the EAA/KAA mixture are given in Table 1 . In order to improve the range and palatability of the diet the patients were issued with a specially prepared vegetarian cook book (JM). The details of the patients' diets were calculated on an individual basis. Four of the patients who were considerably in excess of their desired wt (>6 kg heavier) were given a dietary allowance based on the desired wt. The analysis of the EAA/KAA mixture is shown in Table 2 . This mixture came as a powder which was dissolved in water to make an orange flavoured drink (Scientific Hospital Supplies, Ltd., Liverpool, England). In addition patients received the following supplements: ferrous sulphate, 200 mg daily; zinc sulphate, 220 mg twice weekly; hydroxycobalamin, 1000 p.g every three months; and, Ailbee with C, 1 tablet daily containing 15 mg thiamine, 10 mg riboflavine, 50mg nicotinamide, 5 mg pyridoxine, 10 mg calcium pantothenate and 300 mg ascorbic acid. Hypotensive drugs and fruscmide were prescribed as appropriate for each individual. If the patient was taking aluminum hydroxide at the start of the trial, the dosage was left unchanged for at least three months. Patients not taking this drug only received it after three months if serum phosphate remained above the upper limit of normal. Six patients were prescribed calcium carbonate as an alternative phosphate lowering agent. Alfacalcidol (1 a-hydroxycholecalciferol) had previously been given to three patients for hypocalcemia. This was continued until serum calcium was normal.
Following the start of the trial, patients were seen at monthly intervals for review by both a clinician and a dietitian. 
Laborato,y measurements
The following blood measurements were made using standard laboratory procedures: urea, electrolytes, creatinine, calcium, phosphate, albumin, and full blood count. Total calcium was corrected for serum albumin concentration by 0.02 mmole/liter for each g/liter of albumin above or below 40 g/liter. Parathyroid hormone was measured by immunoradiometric [17] assay using an antiserum recognizing the intact PTH molecule. Transferrin was measured by reaction with a monospecific antibody as assessed by rate nephelometry.
Twenty-four hr urine samples were assayed for urea, creatinine and protein. Changes in renal function were assessed by the slope of reciprocal plasma creatinine, creatinine clearance and combined urea and creatinine clearance when GFR C11 + Ccr [18] .
Nutritional assessment
At the start of the diet patients' height, weight, triceps skinfold thickness (TSF) and mid-arm circumference (MAC) were measured. All except height were remeasured at each monthly visit. The TSF was used as an assessment of body fat. The MAC was converted into a measure of body muscle by the following formula:
I. Mid-arm muscle circumference (MAMC) = MAC -(IT X TSF). The figure of 6.5 represents an estimate of bone area in the upper arm for women. For male subjects a value of 10 was used instead [20] . As a further guide to nutrition the serum values for albumin and transferrin were measured monthly.
Statistical analysis
Changes in biochemical and nutritional measurements were assessed at three month intervals using Student's paired t-test (two tailed). The effect of the diet on the slope of the reciprocal of plasma creatinine was measured by the formula
Results
Clinical response
Initially 19 patients fulfilling our criteria were offered the diet.
Six patients began treatment but were withdrawn from the study within three months because of nausea induced by the EAA/KAA mixture in three, fractured leg (unrelated) in one, and rapidly deteriorating renal function associated with high serum aluminium levels in two patients on an unaltered high intake of aluminium hydroxide. One additional patient eventually admitted total non-compliance. Her results are not considered further.
The remaining 12 patients took the diet for a minimum of six months each. Details of these participants are shown in Table 3 .
Patients continued the regime for up to 12 months and were only discontinued if on clinical and biochemical grounds renal replacement therapy was thought necessary. Six patients were transferred to dialysis, one at 7 months, one at 10 months and the remaining four after at least 12 months. At the time of writing, two patients remain on the regime after more than two years, (patient numbers 5 and 6). Dietary assessment confirmed
Renal function
Prior to starting the trial, renal function as assessed by reciprocal plasma creatinine had been deteriorating steadily in all the patients. The minimum correlation coefficient for the previous reciprocal plasma creatinine for any patient was -0.76, and nine patients had values of -0.92 or greater. The subsequent slope of the reciprocal changed significantly in eight patients becoming less steep, P values ranging from <0.05to < 0.001 (Fig. 1) . The correlation coefficient of reciprocal creatinine against time ranged from + 0.52 to -0.91 after starting the diet. In two patients (numbers 5 and 6) the calculated regression line became positive during a 12 month period on the diet. Ten of the 12 patients had a fall in their plasma creatinine concentration of between 66 and 397 p mole/liter during the first six months of treatment (Fig. I) . The delay in plasma creatinine concentrations reaching a higher value than at the start of the treatment varied from 0 to greater than 12 months.
Creatinine clearance fell by 1.5 1.5 mliter/min for the group as a whole over the first six months of the diet P < 0.005, but the changes over the first and second quarters of the trial did not reach statistical significance. For the seven patients who took the diet for at least 12 months, creatinine clearance decreased by 1.7 1.7 mliter/min during this period, P <0.05. However, four patients had effectively stable function, creatinine clearance changing by less than 0.5 mliter/min in the year.
The values for combined urea and creatinine clearance showed similar changes. During the first six months the combined clearance fell by 0.9 1.2 mliter/min, P < 0.05. The seven patients studied for a year had a fall of 1.3 1.6 mliter/min, NS. The same four patients showing little change in that patients consumed all the keto acid mixture and did not take any extra protein. 6 .51 [19] .
A striking feature during this study was the sense of well being felt by the patients. Prior to starting the diet many had lethargy, nausea and anorexia. After about two months most patients felt much better and spontaneously commented on their improved state. This feeling was maintained even in the presence of declining renal function. We have not however attempted to quantify the severity of symptoms felt by our patients.
The degrees of freedom were given by the number of points on the slopes minus 2.
Where appropriate results are expressed as the mean SD. Metabolic changes
Blood urea fell dramatically in the first three months in all patients, Pc 0.001. The mean value decreased from 31.1 6.8 mmole/liter to 13. 3 6.5 mmole/liter. There was a rise to 19.2 mmole/liter from three to six months, P c 0.005. In those patients who were followed for at least 12 months, the mean drop of 10.7 mmole/liter over the year was still significant, P < 0.05.
Urine urea excretion fell in parallel with the blood urea, total output decreasing by 115 61 mmole/24 hr in the first three months, Pc 0.001. There was a slight rise of 22 25 mmole/24 hr from three to six months, P C 0.02. Analyzing the change over the whole of the first six month period, the mean fall of 91 mmole/24 hr was still highly significant, P c 0.001.
Urine protein excretion was only in the frankly nephrotic range for one patient (number 5) prior to the start of the trial (8.4 g124 hr). During the initial six months of the study there was a mean fall of 1.1 g124 hr in the group as a whole, P C 0.05. The patient with the heaviest proteinuria had a decrease of 5.3 g124 hr during this time.
There was a tendency for the plasma potassium to be raised mmole/liter in the first three months of treatment, during which no change was made in dosage of phosphate binders, P < 0.005. During the initial six months of the study, the mean decrease in phosphate of 0.58 mmole/liter remained statistically significant, P < 0.05. In the six patients who had no change in their dose of phosphate binding agent during this period, the fall in serum phosphate of 0.55 mmole/liter was also significant, P < 0.01. Corrected total serum calcium rose during the initial three months by 0.17 0.2 mmole!liter, P < 0.02. Nine patients received no alfacalcidol or calcium carbonate during this period. Their rise of 0.19 0.2 mmole/liter was also significant, P <0.02. By six months only six subjects had not been prescribed alfacalcidol or calcium carbonate. Their mean value rose from 2.14 0.17 to 2.35 0.1 mmole/liter, P = 0.05. No patient developed hypercalcemia at any time.
The calcium X phosphate product was also calculated. The value fell by 0.96 (mmole/liter)2 during the first three months, P <0.05. By six months the mean value had dropped from 4.85 1.02 to 3.84 1.07 (mmole/liter)2, P < 0.02. Serum PTH levels were measured before and after the first three months of treatment in 11 patients. Values fell in all, P < 0.01 (Fig. 3) . Nine patients received no alfacalcidol during this time and their values fell by 0.62 ng/mliter, P < 0.02.
The hemoglobin concentration remained constant throughout the study period with no statistically significant changes. The mean hemoglobin was 7.87 0.9 g/100 mliter at the start and 7.88 0.91 g/l00 mliter at six months.
Nutritional assessment
Body wt fell in 11 of the 12 patients during the first three months. The mean loss was 3.3 kg, P <0.005. The maximum individual loss was 7.1 kg during this time. Subsequently body wt tended to be more stable. No further statistical analysis has been carried out as several patients required diuretics for edema later in the study.
Triceps skinfold (TSF) dropped by an average of 0.9 mm during the initial three months, P < 0.005, though half the patients had no measured change. From 0 to 6 months the mean difference was -1.4 mm, P < 0.02, though there was no change in five of the group. The seven patients who were on the diet for at least 12 months had a mean fall in TSF of 1 mm, P < 0.02, although two of the group had no observed difference. Two patients with initial falls in TSF regained their losses but no subject showed an increase.
Mid-arm muscle circumference (MAMC) fell by a mean of 0.6 cm during the first three months, P < 0.02, but no change was seen in six of the patients. By six months the mean fall was 0.9 cm, P < 0.005. Only three patients had no change during this period. The seven patients studied for at least 12 months had a mean decrease of 1.7 cm, P < 0.001. The maximum decline in MAMC seen was 2.5 cm. had the heaviest proteinuria. Her serum albumin remained steady throughout the 12 months of the study. The mean transferrin level was 2.37 0.27 g/liter at the start of treatment and 2.37 0.22 after 12 months (normal 2.0 to 4.0 glliter). There were no statistically significant changes in the group as a whole at three, six or 12 months. Small individual differences did not correlate with changes in MAMC.
Crealinine metabolism As noted previously, the majority of patients had a fall in plasma creatinine concentration during the first six months of treatment. In two patients there was a striking association between a fall in plasma creatinine of >300 molc/liter and an estimated loss of muscle mass of 4 kg (Fig. 4) .
The 24 hr urinary excretion of creatininc fell during the initial three months, the mean value decreasing from 7. 14 2.55 to 1.44 mmole, N = 7, P <0.02.
In view of the observed loss of muscle circumference in the majority of patients, the urinary creatinine excretion per 24 hr in mmole was related to estimated muscle mass in kg. During the first six months creatinine excretion per unit muscle mass fell from 0.32 0.06 to 0.26 0.04 mmole/kg/24 hr, P < 0.005. This represents a mean decrease of 21% (rangc 0 to 46%), most of which occurred during the first three months.
Discussion
In view of the increasing number of studies which appear to suggest that low protein diets significantly slow the progress of chronic renal failure [211 the nephrologist might be tempted to prescribe protein restriction for all patients with this condition. It is clearly important, however, that the safety and efficacy of such regimes should be fully tested before their general use is recommended. Our study attempts to clarify some of these issues in relation to very low nitrogen diets supplemented by essential amino acids and keto acids.
Our experience confirms previous findings that those taking a keto acid diet lose their uremic symptoms even in the face of deteriorating renal function [221. There is, however, a minority of subjects who find that the EAA/KAA mixture produces intolerable nausea. This has been noted previously with similar supplements 1231. We found no clinical evidence of an increased incidence of uremic complications such as neuropathy or pencarditis, and Giovanetti [24] has reported that nerve conduction may improve slightly in patients taking a similar regime.
The most important consideration from both a practical and theoretical point of view is whether the diet affected renal function. Arguably the most convenient method of assessing changes in renal function is by use of the slope of reciprocal plasma creatinine [25] . In most cases of chronic renal failure the slope remains constant, provided no new factor such as hypertension intervenes [261. Most previous studies of protein restriction have compared this slope before and after treatment [10, 11, 14, 151 . Using this criterion the majority of our patients (S of 12) had a significant slowing in the rate at which renal function was deteriorating. An alternative means of assessment suggested by Mitch et al [14] is the "delay," or period of time which elapses before the plasma creatinine again reaches its starting value. The majority of our patients had considerable delays, in two cases the delays were longer than 12 months. Our data, however, suggest that the use of plasma creatinine measurements (or their reciprocals) alone is unlikely to lead to a valid assessment of renal function following the introduction of regimes such as ours. The presence of the delay is caused by the plasma creatinine falling, by over 300 imole/liter in some cases, during the first few months of treatment. A corresponding "hump" is therefore seen in the reciprocal plot. This phenomenon also occurred to some ol' the patients in previous studies, that is, patient number 20 in Mitch et a! 114] and patient number 9 in Alvestrand et al [101. Despite this fall in plasma creatinine, there was no improvement in either creatinine clearance or combined urea and creatininc clearance in any of our patients, even in the two whose reciprocal slopes changed from negative to positive.
Thus this delay seems to he caused by an alteration in creatinine metabolism rather than improvement in renal function. At the low levels of renal function of our patients accurate measurements of GFR are difficult to obtain on an outpatient basis. Single shot isotopic techniques such as Cr51-EDTA overestimate true GFR [271. Creatinine clearance or preferably combined urea and creatinine clearance [17, 27] provide a better measure. Few studies on the effects of a diet have reported serial measurements of either of these clearances. Barsotti et al [16] did show that the rate of decline of creatinine clearance was much slower after starting a similar diet. In our study, an inadequate number of clearances performed prior to starting the diet prevented a meaningful analysis. Nevertheless the observation of only very small changes in GFR in four of our patients over the 12 month period suggests a reduction in the rate of deterioration.
An alternative means of assessing the effect of the regime suggested by Mitch et at [14] , is to compare the actual time taken to reach an arbitrary creatinine value with that projected from the pre-treatment reciprocal creatinine plot. With an approximate assessment of the time "spared," renal replacement therapy can then be derived. Using a plasma creatinine value of 1500 mole/liter as an indication of the need to start dialysis, our 12 subjects appeared to have been spared a total of approximately four patient years of renal replacement therapy. Mitch et al [14] reported that their patients on a comparable diet had a similar extended period of freedom from dialysis treatment. However, this method of assessment is still dependent on plasma creatinine, and if this is lowered by non-renal mechanisms, it may not be a realiable measure of the uremic state and thus when to start renal replacement therapy.
The metabolic changes observed in our trial were similar to those previously reported [22] with a marked fall in blood urea. Urine urea excretion fell in parallel with the blood urea during the first three months of treatment. The significant decline in proteinuria is of interest in view of the recent report that the response to a low protein diet correlated with the drop in protein excretion in patients with glomerulonephritis [28] .
There were insufficient numbers of subjects with this group of diseases in our study to confirm this finding.
The changes in calcium and phosphate metabolism are of considerable interest. There was a marked drop in serum phosphate as noted previously [16, 23] . This was accompanied by a small but significant rise in corrected total calcium. Previously it has been reported that patients may develop hypercalcemia with a similar diet [23] but this did not occur in our experience. Despite the rise in calcium the calcium X phosphate product fell as noted before [23] . PTH levels declined in most patients as Barsotti et al [29] also found. Though this fall may have been related to an improved calcium intake from the keto acid salts, the total amount consumed by our patients was only 0.39 mmole/kg/day (15.6 mg/kg/day). Frohling and colleagues [30] reported a fall in parathormone when keto acid supplements were used with moderate protein restriction.
livery low protein diets are to be regarded as safe it is necessary to show that malnutrition does not occur [31] . A number of different techniques have been used to assess nutritional status. These include weight, anthropometry, serum protein levels and nitrogen balance studies. The study of Barsotti et al [16] gave no details of the nutritional effects of a nearly identical regime to ours.
Subsequently Giovanetti [24] claimed that serum protein levels, including transferrin, remained normal and there was no change in thigh muscle circumference. Mitch et al [14] , using a diet given slightly more nitrogen, noted no change in body wt and small rises in serum transferrin and albumin. They did not report anthropometric measurements but found a positive nitrogen balance. Kopple and colleagues [31] , using a diet supplemented by essential amino acids giving an even higher nitrogen intake, reported no change in anthropometry. Our patients did lose wt during the first three months of treatment, but serum albumin remained absolutely normal and transferrin levels did not change significantly.
However, there were marked discrepancies between the direct muscle mass measurements and serum transferrin. Patients 5 and 6 apparently lost 4 kg each of muscle mass during the first six months, having a drop in muscle circumference of at least 2 cm. Yet both had persistently normal levels of serum transferrin. Patient 4 had a rise in serum transferrin at the same time as muscle mass decreased (data not shown). It might be argued that there was a loss of nitrogen during the initial phase of the diet but the muscle changes occurred gradually and not suddenly. It is of course possible that the use of the keto acids in different proportions might have avoided these nutritional problems but we felt it important to use a regime which had already been tried without any apparent serious side effects [13] . Whatever the reason for the discrepancy between anthropometry and the other measures of protein balance, this study strongly suggests that assessment of the nutritional consequences of a low protein diet must include direct measurements of muscle mass by anthropometry since the other commonly used techniques may not reveal significant losses.
We deliberately chose a high calorie intake as we were concerned to minimize the catabolism of protein. Recent studies suggest that a safe minimum level for chronic renal failure patients is 35 kcal/kg/day [32] . Yet despite our prescribed high intake, there was no increase and sometimes a slight fall in body fat. To maintain the level prescribed it was necessary for our patients to consume calorie-containing supplements. It is possible that these were not always taken in sufficient amounts, but assessment by the dietitian suggested that only one patient consumed less than 30 kcallkg/day. Of the rest, nine took consistently in excess of 36 kcal/kg/day.
We have noted above the drop in plasma creatinine occurring with this and similar diets unaccompanied by improvements in GFR. The implication is that the body creatinine pool had somehow decreased. Several factors are likely to be involved: the reduction in dietary creatinine, the loss of muscle mass and possibly alterations in creatinine production or degradation.
Estimates of up to 30% have been made for the proportion of creatinine produced from exogenous sources in normal subjects [33] . However, some of our patients were already on protein restriction before taking the diet and several were anorexic. In two of our patients there was a striking parallelism between plasma creatinine and anthropometrically assessed muscle mass. However, in other patients this fall in creatinine occurred in the absence of measurable changes in muscle circumference. Our patients had a drop in urinary creatinine excretion per unit muscle mass of 21% with individual changes of up to 46%, suggesting altered creatinine metabolism. Endogenous creatinine is derived from creatine at a relatively fixed rate, the process occurring non-enzymatically. Whether this rate of hydrolysis can be changed is unknown. Creatinine is also degraded in the body [34, 35] possibly in the gut [34] . This degradation forms a significant proportion of creatinine metabolism in chronic renal failure [35] . Whether this process can be altered is uncertain but it is possible there was a change in bowel flora during the period on the diet. These alterations in plasma creatinine, muscle mass and creatinine excretion all appeared to occur in the first three to four months on the regime and may represent adaptation to it. A new steady-state appears to be attained after this time.
In conclusion, whether the diet tested in our trial did appear to slow the progression of renal failure is still uncertain. There were, however, disadvantages including the loss of muscle mass. The taking of this regime required considerable dedication on the part of the patients and their families as virtually separate meals had to be prepared. We note that Mitch et al [141 spent a long time on patient education with a similar trial.
Several of our other chronic renal failure subjects declined the diet because of its complexity. We, therefore, do not feel able to recommend it for widespread use. We suspect that a less restricted regime will find much wider patient acceptance with fewer nutritional problems [31] .
Our study revealed that variations in the reciprocal of plasma creatinine do not provide a valid measure of changes in renal function when very low protein diets are used. It is also suggested that anthropometric measurements are essential in any assessment of the nutritional consequences of such regimes.
